Literature DB >> 31823597

Zirconium Oxide Sulfate-Carbon (ZrOSO4@C) Derived from Carbonized UiO-66 for Selective Production of Dimethyl Ether.

Mohamed N Goda, Hani Nasser Abdelhamid, Abd El-Aziz A Said.   

Abstract

Methanol dehydration process to dimethyl ether (DME) has been considered as one of the main routes to produce clean fuel, that is, DME. Thus, efficient catalysts are highly required for selective production of DME. Herein, UiO-66 was used as a precursor for the synthesis of zirconium oxide sulfate embedded carbon (ZrOSO4@C). The synthesis method involves a one-step carbonization of UiO-66 in the presence of sulfuric acid (10 wt %). Material characterizations using X-ray diffraction, X-ray photoelectron spectroscopy, Fourier transform infrared, and Raman spectroscopy approve the formation of the high crystalline phase of ZrOSO4@C. Nitrogen adsorption-desorption isotherms and high-resolution transmission electron microscopy confirm the mesopore structure of the materials. Acidity analysis using pyridine temperature-programmed desorption and isopropanol dehydration corroborates that ZrOSO4@C has weak and intermediate acidic sites making ZrOSO4@C an effective catalyst for methanol dehydration to DME. The materials offered full conversion (100%) with excellent selectivity (100%) at a relatively low temperature (250 °C). The catalyst exhibited a long-term stability for 120 h. Based on these results, DME is produced efficiently in terms of conversion, selectivity, and long-term stability.

Entities:  

Keywords:  ZrOSO4; dimethyl ether; metal−organic frameworks; methanol dehydration; solid acid catalyst

Year:  2019        PMID: 31823597     DOI: 10.1021/acsami.9b17520

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  1 in total

1.  Enhancement of critical-sized bone defect regeneration using UiO-66 nanomaterial in rabbit femurs.

Authors:  Ahmed Abdelrahiem Sadek; Mahmoud Abd-Elkareem; Hani Nasser Abdelhamid; Samia Moustafa; Kamal Hussein
Journal:  BMC Vet Res       Date:  2022-07-05       Impact factor: 2.792

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.